Risk Factors Associated with Antibiotic Multidrug Resistant Nosocomial Infection among Hospitalized Patients Aged 14 years and Older in Nakhon Phanom Hospital
Keywords:
Risk factor, Multidrug Resistant Microorganism Infection, Nosocomial InfectionAbstract
Objectives: Multiple drug-resistant infections can cause patient’s death, or result in longer hospital stays, higher treatment costs and require expensive antibiotics. The aims of this study was to determine the risk factors associated with antibiotic multiple drug-resistant infections among hospitalized patients aged 14 years and over and incidence of antibiotic multiple drug-resistant infections among patients in Nakhon Phanom Hospital. Materials and Methods: A case-control study was conducted among hospitalized patients in Nakhon Phanom Hospital between January 2016 and December 2018 to compare factors associated with antibiotic multidrug resistance between multiple drug-resistant patients with 1-2 groups of drug-resistant patients and non-drug-resistant infections. Data was collected from in-patient charts. Factors studied included sex, age, diabetes and cancer patients, treatment in intensive care unit, having insertion tubes or catheters into the body including endotracheal tube, urine catheter, nasogastric tube, and receiving antimicrobial drugs. Multivariable logistic regression was used for statistical analysis. Result: A total of 461 patients were enrolled: 117 cases and 344 controls. Most of the cases were female (58%), with a mean age of 62 years, had ventilator-associated pneumonia infection (58.1%), most common pathogen being Acinetobacter baumannii (83%), and had an average stay in hospital of 33 days. In the control group, a majority were male (52%), with a mean age of 59 years, had catheter- associated urinary tract infection (32%), most common pathogen being Escherichia coli (22%), and an average stay in hospital of 25 days. Both groups had different outcomes which were statistically significant: 63% improved and 21% died in the case group, while 79% improved and 13% died in the control group. Incidence rate of multidrug resistant infection in 2016, 2017, and 2018 were 0.11%, 0.12%, and 0.16% respectively. Risk factors for antibiotic multiple drug-resistant infections included treatment in intensive care (OR adjusted 1.83, 95%CI 1.00-3.35), intubation with endotracheal tube (aOR 2.47, 95%CI 1.10-5.55) and having received 3rd generation Cephalosporins (aOR 1.92, 95%CI 1.21-3.05). Conclusion: Patients in intensive care unit together with endotracheal tube and receiving 3rd Cephalosporin drugs have a higher chance of antibiotic multiple drug-resistant infections. Studies with more data are needed to better understand the risk factors associated with antibiotic multidrug resistant nosocomial infections in hospital settings.
References
ศูนย์เฝ้าระวังการติดเชื้อดื้อยาต้านจุลชีพแห่งชาติ. (2013). สถานการณ์เชื้อดื้อยาของประเทศไทย. สืบค้นจาก http://narst.dmsc.moph.go.th/whonetmeeting/2.pdf
Centers for Disease Control and Prevention [CDC]. (2014). MRSA Surveillance, In Hospitals. Retrieved from http://www.cdc.gov/mrsa/statistics/MRSA-Surveillance- Summary.html
CDC. Multidrug-Resistant Organism & Clostridium difficile Infection (MDRO/CDI) Module. January 2014. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO CDADcurrent.pdf
Hanberger,H.,Walther, S., Leone, M., Barie, P. S., Rello, J.,Lipman, J. et al. (2011). Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit:results from the EPIC II
study. International Journal of Antimicrobial Agents,38(4),331-335. https://scholar.google.co.th/scholar?cluster=1140104170647084118&hl=th&as_sdt=0,5
Eagye KJ, Kuti JL, Nicolau DP. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol; 2009;30(8):746-52. https://scholar.google.co.th/scholar?cluster=8307974404296548609&hl=th&as_sdt=0,5
Fillice, G. A., Nyman, J. A., Lexau, C., Lee, C. H., Bockstedt, L. A., Como-Sabetti, K., et al. (2010).Excesscost and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infection Control and Hospital Epidemiology, 31, 365-373. https://scholar.google.co.th/scholar?cluster=8307974404296548609&hl
Salgado, C., Gonçalves, J. C., Souza, C. M. D., Silva, N. B. D., Sánchez, T. E. G., Oliveira, G.D., & Karnikowski, M. (2011). Cost of antimicrobial treatment of patients infected with multidrug-resistant organisms in the intensive care unit. Medicina (B Aires). 71(6), 531
ภาณุมาศ ภูมาศ, ตวงรัตน์ โพธะ, วิษณุ ธรรมลิขิตกุล, อาธร ริ้วไพบูลย์, ภูษิต ประคองสาย, สุพล ลิมวัฒนานนท์. ผลกระทบด้านสุขภาพและเศรษฐศาสตร์จากการติดเชื้อดื้อยาต้านจุลชีพ ในประเทศไทย: การศึกษาเบื้องต้น. วารสารวิจัยระบบสาธารณสุข. 2555;6(3):352-360.
World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Available at: apps.who.int/iris/bitstre am/10665/112642/1/9789241564748_eng.pdf.Accessed Aug 26, 2018. :https://scholar.google.co.th/scholar?cites=4105865597082968317&as_sdt=2005&sciodt=0,5&hl=th
กลุ่มงานควบคุมและป้องกันการติดเชื้อ โรงพยาบาลนครพนม. (2018). รายงานเฝ้าระวังการติดเชื้อในโรงพยาบาล.
SIEGEL, Jane D., et al. Management of multidrug-resistant organisms in health care settings, 2006. American journal of infection control, 2007, 35.10: S165-S193. :https://www.cdc.gov/infectioncontrol/guidelines/mdro/
US DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, 2013. :https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
กัลยาณี ศุระศรางค์. (2006). ปัจจัยเสี่ยงของการติดเชื้อดื้อยา Acinetobacter baumannii ในโรงพยาบาลศิริราช. (วิทยานิพนธ์พยาบาลศาสตรมหาบัณฑิต สาขาวิชาเอกโรคติดเชื้อและวิทยาการระบาด). บัณฑิตวิทยาลัย, มหาวิทยาลัยมหิดล. http://www.si.mahidol.ac.th/th/publication/2007/Vol90_ No.8_1633_2880.pdf
Forster, A. J., Oake, N., Roth, V., Suh, K. N., Majewski, J., Leeder, C., & van Walraven, C. (2013). Patient-level factors associated with methicillin-resistant Staphylococcus aureus carriage at hospital admission: A systematic review. American Journal of Infection Control, 41(3), 214-220. doi: http://dx.doi.org/10.1016/j.ajic.2012.03.026
Swati Patolia, Getahun Abata, Nirav Patel, Setu Patolia,and Sharon Frey.(2017). Risk factor and outcomes for multidrug-resistant Gram-negative bacilli bacteremia: https://www.ncbi.nim.nih.gov/pmc/articles/PMC5761922/
นันทิพัฒน์ พัฒนโชติม พรนภา ศุกรเวทย์, ชินวัตร ศรีใส. ปัจจัยที่มีความสัมพันธ์กับการติดเชื้อดื้อยาหลายขนานของเชื้อ Acinetobacter baumannii ในผู้ป่วยในโรงพยาบาบร้อยเอ็ด จังหวัดร้อยเอ็ด. วารสารวิจัยสาธารณสุขศาสตร์ มหาวิทยาลัยขอนแก่น. 2555;5(1):87-95
นฤมล จุ้ยเล็ก, วิลาวัณย์ พิเชียรเสถียร, นงเยาว์ เกษตร์ภิบาล. การพัฒนาระบบการให้คะแนนปัจจัยเสี่ยงของการติดเชื้อดื้อยาหลายกลุ่มสำหรับผู้ป่วย ใน.พยาบาลสาร; 2559 ;43(3):69-80.
Hong-Yu Zhou, Zhe Yuan, Yu-Ping Du.(2014) Prior use four invasive procedures the risk of Acinetobacter boumannii nosocomial bacteremia among patients in intensive care units: a systemic review and meta-analysis.
International journal of Infectious Disease 22(2014) 25-30 https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-017-2932-5.
Spilpa kalluru, Shoshannah Eggers, Anna Barker, Daniel Shirley, Ajay K. Sethi, Shamila Sengupta, Kajal Yeptho, Nasia Safdar: Am J Infect Control. 2018 Mar; 46(3) ; 341-345 https://www.ncbi.nim.nih.gov/pmc/articles/PMC5760232/.
PARKER, Chris M., et al. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. Journal of critical care, 2008, 23.1: 18-26.
https://scholar.google.co.th/scholar?cluster=16947238079996373387&hl=th&as_sdt=0,5
NSEIR, S., et al. Risk of acquiring multidrugresistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clinical Microbiology and Infection, 2011, 17.8: 1201-1208. https://scholar.google.co.th/scholar?
cluster=15890187102535323811&hl=th&as_sdt=0,5
BLANCO, Natalia, et al. Risk factors and outcomes associated with multidrug-resistant acinetobacter baumannii upon intensive care unit admission. Antimicrobial agents and chemotherapy, 2018, 62.1: e01631-17. https://scholar.google.co.th/scholar?cluster=1027079 1613741120540&hl=th&as_sdt=0,5
HUANG, Huiping, et al. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii. BMC infectious diseases, 2018, 18.1: 11. https://scholar.google.co.th/scholar?cluster
=14614415049417775369&hl=th&as_sdt=0,5
Downloads
Published
How to Cite
Issue
Section
License
- บทความที่ได้รับการตีพิมพ์ถือเป็นลิขสิทธิ์ของ โรงพยาบาลนครพนม
- ข้อความหรือข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความนั้นๆ ไม่ใช่ความเห็นของกองบรรณาธิการ